# Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis

> **NCT02596945** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 223 (actual)

## Conditions studied

- Renal Impairment
- Renal Anemia of Chronic Kidney Disease

## Interventions

- **DRUG:** Methoxy polyethylene glycol epoetin beta

## Key facts

- **NCT ID:** NCT02596945
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-31
- **Primary completion:** 2011-02-28
- **Final completion:** 2011-02-28
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02596945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02596945, "Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02596945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*